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BACKGROUND/PURPOSE: The genus Leptospira comprises pathogenic and saprophytic strains. Conven-
tional methods for the identification of pathogenic leptospiral isolates are cumbersome and laborious. In view 
of these limitations, the search for alternative methods have been focused on DNA based techniques. In this 
study, we have developed an effective method for the rapid identification of pathogenic and saprophytic 
leptospiral isolates based on DNA-based techniques.
METHODS: A polymerase chain reaction(PCR)-based approach was developed using specific primer sets (flaB, 
G1-G2, B64I-II, and A-B) to differentiate pathogenic and saprophytic leptospiral strains. Fifty-five leptospiral 
isolates were used for this study. The pathogenic status of the isolates was compared with the results obtained 
using conventional techniques, which included growth in the presence of 8-azaguanine and growth at 13°C.
RESULTS: In this analysis, 46 leptospiral isolates were confirmed as pathogenic and nine were confirmed 
as saprophytic. PCR with the A-B primer set yielded an amplified product of 331 bp in all of the patho-
genic and saprophytic isolates. The other primer sets, G1-G2, B64I-II and flaB, yielded products of 
258 bp, 568 bp, and 793 bp, respectively, exclusively for the pathogenic leptospiral strains. None of the 
saprophytic strains yielded products with these primer sets.
CONCLUSION: The flaB-specific primers consistently yielded an amplification product for all of the 
pathogenic leptospiral isolates, indicating the presence of the flaB gene only among pathogenic lepto-
spires, and making this a useful tool for distinguishing between pathogenic and saprophytic leptospires. 
The efficiency of PCR-based identification corroborates the implementation of these techniques for the 
identification of pathogenic and saprophytic leptospiral strains.
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Introduction
Leptospirosis is considered the most widespread zoonotic 
disease in the world, occurring in a variety of urban and 
rural settings. Leptospirosis is caused by infection with 
pathogenic Leptospira species and can frequently lead to 
life-threatening disease in humans. It is characterized by 
hematogenous dissemination of the bacteria to multiple 
organs including the brain, aqueous humor, liver, lungs, 
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and kidneys.1 Heterologous Leptospira species can cause 
disease and more than 300 serovars of Leptospira interrogans 
sensu lato and 45 serovars of Leptospira biflexa sensu lato 
have been described.2 These pathogenic leptospires are re-
sponsible for human/animal infections. The pathogenic 
mechanisms of leptospires are not clearly defined but poten-
tial virulence factors include hemolysins, glycolipoproteins, 
heat shock proteins, and flagella.3
The saprophytic leptospires are indigenous to fresh sur-
face water and to date, a clear parasitic or saprophytic role 
has not been established for these organisms. Mammals 
are not susceptible to experimental infection by these 
leptospires.4 These pathogenic leptospires commonly in-
habit the mammalian kidney and organisms are therefore 
excreted through urine. The presence of pathogenic lepto-
spires in streams and water bodies is an index of leptospiro-
sis in wildlife or domestic animals having access to these 
waters. Differentiation of pathogenic from saprophytic lept-
ospires is important to classify the pathogenic status of 
the leptospires for epidemiological and taxonomical purposes.
Recently, species-specific primers which amplify the 16S 
and 23S rRNA regions and a portion of the flaB gene coding 
for the flagellar protein have been developed for the identifi-
cation of pathogenic and saprophytic leptospires.5–7 In an 
earlier study, the leptospiral strains belonging to similar se-
rovars recovered from patients presenting with different 
clinical manifestations were compared using the randomly 
amplified polymorphic DNA fingerprinting technique, to 
understand the clonal relatedness and distribution of these 
strains.8 The standard methods available for the differentia-
tion of pathogenic from saprophytic leptospires are growth 
in the presence of 8-azaguanine and growth at 13°C.
In this study, polymerase chain reaction (PCR) amplifi-
cation was performed using four primer sets ( flaB, G1-G2, 
B64I-II and A-B) on the leptospiral isolates recovered from 
various sources to distinguish the pathogenic and sapro-
phytic leptospires. The results were compared with those 
obtained using the standard methods of growth in the 
presence of 8-azaguanine and growth at 13°C.
Methods
Leptospira strains
A total of 55 leptospiral isolates, of various serovars, re-
covered from different sources, were included in this 
study. All of the strains were maintained in the leptospiral 
repository of the Regional Medical Research Centre, Port 
Blair, Andaman Islands, India with periodical subculture in 
Ellinghausen-McCullough-Johnson-Harris (EMJH) me-
dium. Commercial EMJH (Difco, Detroit, Michigan, USA) 
medium was used, with the addition of 0.2% agarose (Sigma, 
St. Louis, MO, USA), 1% bovine serum albumin (Sigma), 2% 
rabbit serum, 0.1% sodium pyruvate (Merck, Germany) and 
100 μg/mL 5-flurouracil (Merck) as a selective agent.
Isolation of leptospires from humans
Individual consent was obtained from patients or their 
guardians and ethical clearance for sample collection was 
obtained from the ethical committee of the Regional 
Medical Research Centre. Blood samples (1–2 drops) from 
clinically suspected human cases of leptospirosis were imme-
diately used to inoculate EMJH semisolid medium. Urine 
samples were processed according to standard procedures.9 
Urine samples (1–4 drops) were used to inoculate EMJH 
semisolid medium in McCartney bottles, with a hole cut in 
the aluminum cap and a rubber lining placed underneath.10
Isolation of leptospires from rat kidney
Trapped field rats (Rattus norvegicus) were sacrificed by cer-
vical dislocation, then washed in cetrimide solution. The 
body cavity was opened aseptically and a piece of kidney 
was extracted using rat toothed forceps and used to inoc-
ulate media in tubes, as described previously.11
Isolation of leptospires from water
Water samples collected from endemic areas were centri-
fuged at 5000g and 1–3 mL of the supernatant was filtered 
through 0.22 μm nitrocellulose membrane filters (Millipore, 
Cork, Ireland) and aseptically added to EMJH medium.4 All 
of the samples were inoculated into three sets of EMJH sem-
isolid media tubes and the tubes were incubated at 30°C in 
the dark. The tubes were examined at weekly intervals by 
dark field microscopy for the presence of leptospires. Tubes 
showing evidence of growth were subcultured into fresh 
EMJH semisolid media vials and further monitored.
Growth of leptospires with 8-azaguanine
A total of 0.5 mL of 8-azaguanine solution (2.25 mg/mL; 
Sigma) was added aseptically to 4.5 mL of EMJH media 
and mixed thoroughly. The tubes were then inoculated 
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with 0.5 mL of a well-grown culture of the test strain along 
with the controls in duplicate. The tubes were incubated at 
30°C and examined twice a week up to 21 days.12 For 
growth at 13°C, 0.5 mL of the strain under investigation 
was subcultured in 4.5 mL of EMJH medium in duplicate. 
Then the tubes were incubated at 13°C and examined twice 
a week up to 21 days.13 A pathogenic strain (RGA) and a 
saprophytic strain (Patoc I) were included as controls.
Serovar level identification of the isolates
A microscopic agglutination test using group sera was ap-
plied for the serogroup level identification and monoclonal 
antibodies (mAbs) of specific serovars were used for the se-
rovar level identification. Both techniques were performed 
as previously described.1 A panel of 37 “group sera” (rabbit 
antisera) representative of all pathogenic serogroups were 
used. To determine the serovar status of isolates, a panel 
of mouse mAbs (WHO/FAO Collaborating Centre for 
Reference and Research, KIT-Biomedical Research, 
Amsterdam, The Netherlands) belonging to serogroups: 
Grippotyphosa (F71C3, F71C9, F165C3, F165C8); 
Icterohaemorrhagiae (F52C1, F70C4, F70C14, F70C20, 
F70C24); Autumnalis (F69C15, F64C10, F69C11, F69C9); 
Australis (F81C1, F81C8, F90C5, F90C6); Sejroe (F13C193, 
F106C53, F16C28, F21C2); Hebdomadis (F50C3, F106C5); 
Javanica (F20C4, F98C8, F98C12, F98C19, F98C20); Pyro-
genes (F134C6); Pomona (F46C9, F46C6); and Canicola 
(F152C11, F152C14, F152C17, F152C18) were used.
Preparation of genomic DNA
Genomic DNA was extracted and purified according to 
the method described previously.14 Exponentially growing 
Leptospira cultures were centrifuged at 12,000g for 30 min-
utes at 4°C. The pellet was resuspended in Tris-EDTA 
buffer (10 mM Tris, 10 mM MgCl2, 2 mM EDTA, 400 mM 
NaCl, and 10 mM KCl) with lysozyme (5 mg/mL) and 
proteinase K (10 mg/mL) and then lysed in CTAB/NaCl 
solution (CTAB, 270 mm; NaCl, 700 mm). The mixture 
was then subjected to chloroform-isoamyl alcohol extrac-
tion and ethanol precipitation. After washed twice with 
70% ethanol, the pellet was dried and then dissolved in 
Milli-Q water and used for PCR analysis.
PCR amplification
PCR was carried out in a 50 μL reaction mixture, con-
tained 50 ng of purified DNA, 0.1 μM of each primer, 
250 μM of dNTP (Genei, Bangalore, India), 3 mM of 
MgCl2, 0.5 U of Taq DNA Polymerase (NEB, MA, USA), 
in 10 mM Tris-HCl (pH 9) and 50 mM KCl. Four sets 
of primers were used in the PCR, according to the stand-
ard procedures described previously.5–7 Primers sequenced 
were listed in Table 1. Initiation at 94°C for 5 minutes, 
followed by 30 cycles of denaturation at 94°C for 
1 minute, annealing at specific temperature for each 
primer pair for 59 seconds (Table 1), extension at 72°C 
for 1 minute, and final extension at 72°C for 7 minute. 
PCR was performed in a DNA Engine PTC 200 thermal 
cycler (MJ Research Inc., USA). The PCR products 
were electrophoresed in a 1.5% agarose gel along with a 
100 bp DNA ladder (Bangalore, Genei, India) in TAE 
buffer containing 0.5 μg/mL ethidium bromide. The 
PCR products were viewed under UV illumination 
and documented using a gel documentation system 
(Bio-Rad, USA).
Table 1. Primer sequences used in this study5–7
Gene  Primer Sequences Annealing (°C)
G1-G2 forward 5-CTG AAT CGC TGT ATA AAA GT-3 60
 reverse 5-GGA AAA CAA ATG GTC GGA AG-3
B64I-II forward 5-CTG AAT TCT CAT CTC AAC TC-3 60
 reverse 5-GCA GAA ATC AGA TGG ACG AT-3
flaB forward 5-TCT CAC CGT TCT CTA AAG TTC AAC-3 59
 reverse 5-CTG AAT TCG GTT TCA TAT TTG CC-3
A-B forward 5-GGC GGC GCG TCT TAA ACA TG-3 62
 reverse 5-TTC CCC CCA TTG AGC AAG ATT-3
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Results
In total, 55 leptospiral isolates from various sources, in-
cluding human blood (n = 40), human urine (n = 2), rat kid-
ney (n = 5), cow urine (n = 1), dog blood (n = 2), and water 
bodies (n = 5) were used for this study. The isolates from 
human specimens were collected from patients with sus-
pected leptospirosis. Serovar level identification of the iso-
lates was carried out using 37 group sera in a cross 
agglutination test and was further confirmed by serovar 
specific mAbs using a microscopic agglutination test. 
The serovar status of the pathogenic and the unclassified 
non-pathogenic isolates can be seen in Tables 2 and 3. 
The mAb patterns observed for the pathogenic isolates 
are presented in Figure 1. Of the 55 isolates obtained, 22 
belonged to serogroup Grippotyphosa, six to serogroup 
Pomona, five to serogroup Icterohaemorrhagiae, five to se-
rogroup Canicola, three to serogroup Australis, and one 
belonged to each of the following serogroups: Pyrogenes, 
Sejroe, Autumnalis, Hebdomadis, and Javanica. The re-
maining nine were unclassified. The pathogenic status of 
the isolates were initially determined by conventional tech-
niques, such as growth in the presence of 8-azaguanine and 
growth at 13°C. Inoculated tubes were incubated up to 21 
days and the tubes were observed at days 0, 7, 14, and 21, 
and the number of leptospires was recorded under dark 
field microscopy with a magnification of (10˜ and 20˜).15 
The maximum number of leptospires observed for patho-
genic isolates was in the range of 10–150, during the 21-
day incubation period, and for saprophytic isolates it was 
in the range of 400–1,020 organisms/field. When compar-
ing the standard procedure results with the group sera 
analysis, 46 isolates were classified as pathogenic and nine 
as saprophytic. The saprophytic isolates did not react with 
any of the 37 group sera of the pathogenic serovars represent-
ing the 23 serogroups in the cross agglutination test and 
were categorized as unclassified isolates. The saprophytic 
isolates also did not show any agglutination with the hyper 
immune sera raised against the saprophytic strain Patoc I.
Apart from the conventional identification methods, 
PCR-based methods were also employed using specific 
primers for the flaB gene, the G1-G2 region, the B64I-II 
region and the A-B region, and the product sizes are 
shown in Figure 2. The leptospiral flaB gene was detected 
in all of the 46 pathogenic isolates, the G1-G2 region 
amplified in 44 isolates and the B64I-II region amplified 
in two isolates. A 793 bp fragment was amplified using 
the flaB-specific primers in the pathogenic leptospiral iso-
lates. Amplification of the A-B region yielded a product of 
331 bp in all of the isolates, which corresponded to nucle-
otides 38–57 and 348–368 in the L. interrogans 16S rRNA 
gene. These primer sets therefore amplified a specific por-
tion of the DNA invariably from all of the pathogenic and 
saprophytic leptospires.6 The G1-G2 primers amplified a 
product of 285 bp from all of the pathogenic isolates of 
non-Leptospira kirschneri groups whereas the B64I-II 
primers yielded a product of 563 bp from L. kirschneri. 
Interestingly, the strains shown to be pathogenic lepto-
spires by conventional techniques were confirmed by the 
PCR-based approaches. As with the PCRs for the G1-G2 
and B64I-II regions, the flaB PCR yielded a consistent am-
plification product with all pathogenic strains, indicating 
conservation of this gene amongst pathogenic leptospires.
Discussion
Conventional methods for the identification of patho-
genic leptospiral isolates are time consuming and labori-
ous and there is, therefore, a need for a rapid and simple 
molecular based identification method as an alternative. 
In earlier studies, a single set of G1-G2 primers along with 
A-B primers were used for the identification of pathogenic 
leptospires.16 However, this approach does not accurately 
detect L. kirschneri strains and may wrongly classify patho-
genic strains of L. kirschneri as saprophytic strains. This 
may be overcome by using another set of primers, B64I-II, 
which specifically amplify L. kirschneri. In southern India, 
L. kirschneri is one of the prevailing species and therefore a 
multiplex PCR, including both the G1-G2 and B64I-II 
primer sets, is essential for accurate identification of lept-
ospires.18 In one study, multiplex PCR was performed on 
urine samples collected from patients, but they focused 
on diagnosis rather than identification of the species.17 In 
another study, a nested PCR-restriction fragment length 
polymorphism assay was developed for the identification 
of the predominant pathogenic species in clinical samples 
for the early diagnosis of leptospirosis.19 Recently, many 
techniques have been applied to the identification of 
Leptospira species, such as randomly amplified polymor-
phic DNA fingerprinting and a three-step procedure with 
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Table 2. Serovar and the pathogenic status of the leptospiral isolates
Sample Isolate Serovar Source Pathogenic status
 1 MG347 Australis Human blood Pathogenic
 2 AHF651 Australis Human blood Pathogenic
 3 MG392 Australis Human blood Pathogenic
 4 N2 Autumnalis Human urine Pathogenic
 5 PAI Canicola Human urine Pathogenic
 6 H12 Canicola Human blood Pathogenic
 7 IAH Canicola Human blood Pathogenic
 8 D14 Canicola Dog blood Pathogenic
 9 D7 Canicola Dog blood Pathogenic
10 H22 Grippotyphosa Human blood Pathogenic
11 DS15 Grippotyphosa Human blood Pathogenic
12 DCHCF30 Grippotyphosa Human blood Pathogenic
13 ALC10 Grippotyphosa Human blood Pathogenic
14 R41 Grippotyphosa Rat kidney Pathogenic
15 R42 Grippotyphosa Rat kidney Pathogenic
16 D22 Grippotyphosa Human blood Pathogenic
17 MG472 Grippotyphosa Human blood Pathogenic
18 DS18 Grippotyphosa Human blood Pathogenic
19 BL10 Grippotyphosa Human blood Pathogenic
20 MG670 Grippotyphosa Human blood Pathogenic
21 MG100 Grippotyphosa Human blood Pathogenic
22 MG23 Grippotyphosa Human blood Pathogenic
23 MG11 Grippotyphosa Human blood Pathogenic
24 TB19 Grippotyphosa Human blood Pathogenic
25 Thankachan Grippotyphosa Human blood Pathogenic
26 H2 Grippotyphosa Human blood Pathogenic
27 Mg373 Grippotyphosa Human blood Pathogenic
28 Mg663 Grippotyphosa Human blood Pathogenic
29 MG569 Grippotyphosa Human blood Pathogenic
30 GC1 Grippotyphosa Human blood Pathogenic
31 TB6 Grippotyphosa Human blood Pathogenic
32 ALC1 Hebdomadis Human blood Pathogenic
33 AF61 Icterohaemorrhagiae Human blood Pathogenic
34 GC3 Icterohaemorrhagiae Human blood Pathogenic
35 AHFY Icterohaemorrhagiae Human blood Pathogenic
36 APSK1 Icterohaemorrhagiae Rat kidney Pathogenic
37 APSK2 Icterohaemorrhagiae Rat kidney Pathogenic
38 R1 Javanica Rat kidney Pathogenic
39 H578 Pomona Human blood Pathogenic
40 MG39 Pomona Human blood Pathogenic
41 289MC Pomona Human blood Pathogenic
42 H3 Pomona Human blood Pathogenic
43 L36 Pomona Human blood Pathogenic
44 H48 Pomona Human blood Pathogenic
45 DrGhoshA Pyrogenes Human blood Pathogenic
46 AHF421 Sejroe Human blood Pathogenic
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Figure 1. The monoclonal antibody pattern of the pathogenic leptospiral isolates.
amplified fragment length polymorphism,20 but all of these 
approaches require a high degree of expertise for analysis 
of the results. Furthermore, these molecular-based tech-
niques only determine the species and not the serovar status 
of the isolates. Therefore, we established a PCR assay 
that included the flaB primers as well as the A-B primers, 
to simplify the experimental approach for identifying 
pathogenic Leptospira species. The flaB primers only am-
plify a specific fragment from pathogenic leptospires, al-
lowing rapid identification of pathogenic isolates. The 
G1-G2 and B64I-II primer sets can be used in both single 
and multiplex PCR (data not shown). The A-B primer set 
amplifies a DNA fragment from both pathogenic and sap-
rophytic leptospires. Together with the flaB PCR result, the 
Table 3. Pathogenic status of the unclassified leptospiral isolates
Sample  Isolate Serovar Source Pathogenic Status
1 G3 Unclassified Human blood Non-pathogenic
2 G6 Unclassified Human blood Non-pathogenic
3 W41 Unclassified Pond water Non-pathogenic
4 DrGhoshB Unclassified Human blood Non-pathogenic
5 WTS1 Unclassified Pond water Non-pathogenic
6 WTS2 Unclassified Pond water Non-pathogenic
7 WT62 Unclassified Pond water Non-pathogenic
8 WT11 Unclassified Pond water Non-pathogenic
9 C5 Unclassified Cow urine Non-pathogenic
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pathogenic leptospires can be distinguished from the sapro-
phytic leptospires. To conclude, the flaB PCR-based approach 
is an effective method for the rapid preliminary identifi-
cation of the pathogenic nature of leptospiral isolates.
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